HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS - ANVISA Registration 82149920078

Access comprehensive regulatory information for HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 82149920078 and manufactured by DNA-TECHNOLOGY, RESEARCH & PRODUCTION. The registration is held by GENESTAR INOVAÇÕES E EQUIPAMENTOS MÉDICOS LTDA with validity until Sep 02, 2034.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT IRELAND DIAGNOSTIC DIVISION, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
82149920078
2 Related Devices
Registration Details
ANVISA Registration Number: 82149920078
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Kit de PCR em Tempo Real para Detecção de Citomegalovírus (N)
Risk Class IV

Registration Details

82149920078

25351180301202434

35489323000175

Company Information

Russia
PT: RÚSSIA (FEDERAÇÃO RUSSA)

Dates and Status

Sep 02, 2024

02/09/2034

09/18/2025 19:00:01

Kit de PCR em Tempo Real para Detecção de Citomegalovírus (N)
Risk Class IV

Registration Details

82149920078

25351180301202434

35489323000175

Company Information

Dates and Status

Sep 02, 2024

02/09/2034

09/18/2025 19:00:01